Munich
|
September 24, 2026
Capmont announces the sale of its stake in ITM Isotope Technologies Munich SE
Capmont announces that it has sold its minority shareholding in ITM Isotope Technologies Munich SE (“ITM”) as part of the merger of ITM with Telix Pharmaceuticals Limited (ASX / Nasdaq: TLX), which the two companies announced on 21 September 2026.